Bibliographic Details
| Title: |
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. |
| Authors: |
Löwenberg B; Daniel den Hoed Cancer Center, University Hospital, Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands. lowenberg@haed.azr.nl, Suciu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R, Dekker AW, Berneman ZN, Thyss A, van der Lelie J, Sonneveld P, Visani G, Fillet G, Hayat M, Hagemeijer A, Solbu G, Zittoun R |
| Source: |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1998 Mar; Vol. 16 (3), pp. 872-81. |
| Publication Type: |
Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. |
| Journal Info: |
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
